- Home
- ADNT vs INMD Comparison
ADNT vs INMD Comparison
Compare ADNT & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADNT
- INMD
- Stock Information
- Founded
- ADNT 2016
- INMD 2008
- Country
- ADNT Ireland
- INMD Israel
- Employees
- ADNT N/A
- INMD N/A
- Industry
- ADNT Auto Parts:O.E.M.
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ADNT Consumer Discretionary
- INMD Health Care
- Exchange
- ADNT Nasdaq
- INMD Nasdaq
- Market Cap
- ADNT 1.4B
- INMD 1.5B
- IPO Year
- ADNT N/A
- INMD 2019
- Fundamental
- Price
- ADNT $16.95
- INMD $18.90
- Analyst Decision
- ADNT Hold
- INMD Buy
- Analyst Count
- ADNT 9
- INMD 5
- Target Price
- ADNT $21.88
- INMD $22.25
- AVG Volume (30 Days)
- ADNT 1.3M
- INMD 895.5K
- Earning Date
- ADNT 01-28-2025
- INMD 02-04-2025
- Dividend Yield
- ADNT N/A
- INMD N/A
- EPS Growth
- ADNT N/A
- INMD N/A
- EPS
- ADNT N/A
- INMD 2.25
- Revenue
- ADNT $14,523,000,000.00
- INMD $394,818,000.00
- Revenue This Year
- ADNT N/A
- INMD $1.92
- Revenue Next Year
- ADNT $1.42
- INMD $5.31
- P/E Ratio
- ADNT N/A
- INMD $8.40
- Revenue Growth
- ADNT N/A
- INMD N/A
- 52 Week Low
- ADNT $15.71
- INMD $14.87
- 52 Week High
- ADNT $35.94
- INMD $23.46
- Technical
- Relative Strength Index (RSI)
- ADNT 46.10
- INMD 61.38
- Support Level
- ADNT $16.66
- INMD $18.45
- Resistance Level
- ADNT $17.89
- INMD $19.43
- Average True Range (ATR)
- ADNT 0.70
- INMD 0.56
- MACD
- ADNT 0.03
- INMD 0.10
- Stochastic Oscillator
- ADNT 56.65
- INMD 83.01
About ADNT Adient plc
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.